Bone Loss Recruiting Phase 3 Trials for Alendronic acid (DB00630)

Back to Bone Loss

Also known as: Osteopenia / Osteopenia (disorder) / Osteopenia (morphologic abnormality) / Osteopaenia

IndicationStatusPhase
DBCOND0031952 (Bone Loss)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs